New drug trial offers hope for Brain-Injured newborns

NCT ID NCT05514340

First seen Jan 07, 2026 · Last updated Apr 08, 2026 · Updated 17 times

Summary

This study is testing whether an experimental drug called sovateltide can help newborns who suffered brain injury from lack of oxygen during birth. The drug aims to protect and repair brain cells. Researchers will compare sovateltide against a placebo in 40 newborns to see if it reduces death or severe disability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXIC-ISCHEMIC ENCEPHALOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Christian Medical College and Hospital

    RECRUITING

    Ludhiana, Punjab, 141008, India

    Contact Email: •••••@•••••

  • Father Muller Medical College Hospital

    RECRUITING

    Mangalore, Karnataka, 575002, India

    Contact Email: •••••@•••••

  • GSVM Medical College

    NOT_YET_RECRUITING

    Kanpur, Uttar Pradesh, 208002, India

    Contact

  • Niloufer Hospital

    NOT_YET_RECRUITING

    Hyderabad, Telangana, 500 004, India

    Contact

Conditions

Explore the condition pages connected to this study.